Cavia porcellus skin

Identification

Summary

Cavia porcellus skinis an extract from Cavia porcellus skin used in allergy testing.

Generic Name
Cavia porcellus skin
DrugBank Accession Number
DB10416
Background

Cavia porcellus skin or pelt is used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • Guinea pig skin extract

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

药物产品信息从10 +全球地区
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image
Cavia Porcellus Skin Injection, solution 0.05 g/1mL Percutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US flag
Cavia Porcellus Skin Injection, solution 0.05 g/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US flag
Cavia Porcellus Skin Injection, solution 0.10 g/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US flag
Cavia Porcellus Skin Injection, solution 1000 [PNU]/1mL Intradermal ALK-Abello, Inc. 1965-01-01 Not applicable US flag
Cavia Porcellus Skin Injection, solution 10000 [PNU]/1mL Subcutaneous ALK-Abello, Inc. 1965-01-01 Not applicable US flag
Guinea Pig Epithelia Solution 0.001 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US flag
Guinea Pig Epithelia Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US flag
Guinea Pig Epithelia Solution 10000 [PNU]/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US flag
Guinea Pig Epithelia Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US flag
Guinea Pig Epithelia Solution 20000 [PNU]/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US flag
Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image
Guinea Pig Hair and Epithelia Cavia porcellus skin(0.5 g/20mL)+Cavia porcellus hair(0.5 g/20mL) Injection, solution Percutaneous; Subcutaneous Allergy Laboratories, Inc. 1967-12-07 Not applicable US flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
GM3H4U6QS8
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910585
RxNav
852298

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Form Route Strength
Injection, solution Intradermal 1000 [PNU]/1mL
Injection, solution Percutaneous 0.05 g/1mL
Injection, solution Subcutaneous 0.05 g/1mL
Injection, solution Subcutaneous 0.10 g/1mL
Injection, solution Subcutaneous 10000 [PNU]/1mL
Injection Cutaneous; Intradermal; Subcutaneous 0.05 g/1mL
Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL
Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL
Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/1mL
Solution Intradermal; Percutaneous; Subcutaneous 10000 [PNU]/1mL
Solution Intradermal; Percutaneous; Subcutaneous 20000 [PNU]/1mL
Injection, solution Intradermal; Subcutaneous 0.05 g/1mL
Injection, solution Intradermal; Subcutaneous 0.1 g/1mL
Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL
Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL
Injection, solution Percutaneous; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53